INSULET CORPORATION Selling, General and Administrative Expense
INSULET CORPORATION (PODD) reported Selling, General and Administrative Expense of $344.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- INSULET CORPORATION selling, general and administrative expense for the quarter ending 2026-06-30 was $344.80M, a 33.80% increase year-over-year.
- INSULET CORPORATION selling, general and administrative expense for the quarter ending 2026-03-31 was $317.20M, a 21.67% increase year-over-year.
- INSULET CORPORATION selling, general and administrative expense for the quarter ending 2025-12-31 was $331.40M, a 27.02% increase year-over-year.
- INSULET CORPORATION selling, general and administrative expense for the quarter ending 2025-09-30 was $315.20M, a 34.64% increase year-over-year.
- INSULET CORPORATION selling, general and administrative expense for fiscal 2025 was $1.17B, a 27.02% increase from fiscal 2024.
- INSULET CORPORATION selling, general and administrative expense for fiscal 2024 was $917.20M, a 24.82% increase from fiscal 2023.
- INSULET CORPORATION selling, general and administrative expense for fiscal 2023 was $734.80M, a 25.01% increase from fiscal 2022.
- INSULET CORPORATION selling, general and administrative expense for fiscal 2022 was $587.80M, a 26.14% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $344.80M 10-Q · filed 2026-08-05 | $662.10M 10-Q · filed 2026-08-05 | $993.40M derived: sum of 3 quarters · filed 2026-08-05 | $1.31B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $317.20M 10-Q · filed 2026-05-06 | $648.60M derived: sum of 2 quarters · filed 2026-05-06 | $963.80M derived: sum of 3 quarters · filed 2026-05-06 | $1.22B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $331.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $646.60M derived: sum of 2 quarters · filed 2026-02-18 | $904.30M derived: sum of 3 quarters · filed 2026-08-05 | $1.17B 10-K · filed 2026-02-18 | ||||
| 2025-09-30 | $315.20M 10-Q · filed 2025-11-06 | $572.90M derived: sum of 2 quarters · filed 2026-08-05 | $833.60M 10-Q · filed 2025-11-06 | $1.09B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $257.70M 10-Q · filed 2026-08-05 | $518.40M 10-Q · filed 2026-08-05 | $779.30M derived: sum of 3 quarters · filed 2026-08-05 | $1.01B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $260.70M 10-Q · filed 2026-05-06 | $260.60M 10-Q · filed 2025-05-09 | $521.60M derived: sum of 2 quarters · filed 2026-05-06 | $755.70M derived: sum of 3 quarters · filed 2026-05-06 | $978.20M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $260.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $495.00M derived: sum of 2 quarters · filed 2026-02-18 | $717.50M derived: sum of 3 quarters · filed 2026-02-18 | $917.20M 10-K · filed 2026-02-18 | ||||
| 2024-09-30 | $234.10M 10-Q · filed 2025-11-06 | $456.60M derived: sum of 2 quarters · filed 2025-11-06 | $656.30M 10-Q · filed 2025-11-06 | $656.20M 10-Q · filed 2024-11-08 | $869.00M derived: sum of 4 quarters · filed 2026-02-18 | |||
| 2024-06-30 | $222.50M 10-Q · filed 2025-08-07 | $222.40M 10-Q · filed 2024-08-09 | $422.20M 10-Q · filed 2025-08-07 | $422.10M 10-Q · filed 2024-08-09 | $634.90M derived: sum of 3 quarters · filed 2026-02-18 | $815.60M derived: sum of 4 quarters · filed 2026-02-18 | ||
| 2024-03-31 | $199.70M 10-Q · filed 2025-05-09 | $412.40M derived: sum of 2 quarters · filed 2026-02-18 | $593.10M derived: sum of 3 quarters · filed 2026-02-18 | $771.80M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2023-12-31 | $212.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $393.40M derived: sum of 2 quarters · filed 2026-02-18 | $572.10M derived: sum of 3 quarters · filed 2026-02-18 | $734.80M 10-K · filed 2026-02-18 | $734.90M 10-K · filed 2024-02-23 | |||
| 2023-09-30 | $180.70M 10-Q · filed 2024-11-08 | $359.40M derived: sum of 2 quarters · filed 2024-11-08 | $522.10M 10-Q · filed 2024-11-08 | $666.40M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $178.70M 10-Q · filed 2024-08-09 | $341.40M 10-Q · filed 2024-08-09 | $485.70M derived: sum of 3 quarters · filed 2025-02-21 | $626.10M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $162.70M 10-Q · filed 2024-05-10 | $307.00M derived: sum of 2 quarters · filed 2025-02-21 | $447.40M derived: sum of 3 quarters · filed 2025-02-21 | $621.80M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $144.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $284.70M derived: sum of 2 quarters · filed 2025-02-21 | $459.10M derived: sum of 3 quarters · filed 2025-02-21 | $587.80M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | $140.40M 10-Q · filed 2023-11-03 | $314.80M derived: sum of 2 quarters · filed 2023-11-03 | $443.50M 10-Q · filed 2023-11-03 | |||||
| 2022-06-30 | $174.40M 10-Q · filed 2023-08-09 | $303.10M 10-Q · filed 2023-08-09 | ||||||
| 2022-03-31 | $128.70M 10-Q · filed 2023-05-05 | |||||||
| 2021-12-31 | $466.00M 10-K · filed 2024-02-23 | |||||||
| 2020-12-31 | $384.00M 10-K · filed 2023-02-24 | |||||||
| 2019-12-31 | $298.00M 10-K · filed 2022-02-24 | |||||||
| 2018-12-31 | $248.00M 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |